LONDON, UK, 13 May 2019 – WINCHESTER MD LIMITED (“Winchester” or the “Company”) is pleased to announce that on 09 May 2019 the Company appointed Fraser McGee (“McGee”) as Chief Legal Officer and Regulatory Affairs at its head office in London.
McGee is a UK qualified solicitor who has specialised in corporate finance and investment fund work with prominent law firms in the UK before moving to work in in-house with investment banks. He was also admitted as a solicitor of the Eastern Caribbean Supreme Court and has worked for a BVI and Cayman Islands offshore law firm.
McGee previously worked as general counsel in the Special Situations team, Energy and Technology Fund, at the globally focused hedge fund RAB Capital plc. McGee was also the CEO of an AIM quoted natural resources business before setting up an independent consultancy company to provide general counsel services to the alternative investment sector. That work extended to the European medical cannabis space from the early part of 2018 and included working with networks of entrepreneurs, professional service providers and investors in the industry around the world.
“The global cannabis industry is highly regulated with varying laws by Country. We recognized the need to bring on a Chief Legal Officer and Regulatory Affairs position early in our growth plan to ensure we are on top of the cannabis regulations as they change. This gives the Company the edge in the industry in order to quickly adapt to conform with regulation and monetize a return for our shareholders. McGee is one of the very few city professionals who have actual experience in the Cannabis industry. He brings to the Company a breadth of legal experience in private equity and investment banking which fits well with our fundraising strategy. In addition, we are moving at a rapid speed to grow Winchester not only organically but also by way of acquisition. McGee will be an integral part of our aggressive acquisition strategy.” Explains Faz Moshfeghi, CEO of Winchester.
For more information, please visit www.winchestermd.com
On Behalf of the Board,
About Winchester MD Limited
Winchester MD is a vertically integrated European cannabis company based out of London, UK. The Company was founded in 2018 with an initial focus on CBD Wellness through a revenue producing online retail superstore platform HempElf www.hempelf.com. The Company offers a variety of CBD branded products through its on line superstore and continues to develop and market new products in the CBD Wellness category. In 2019 the Company has expanded into other verticals in the cannabis sector with the vision of becoming a global cannabis leader with cultivation, extraction, CBD wellness and research and development.
This release has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Therefore this release has not been subject to the procedures and controls which would apply if they were made or approved as a financial promotion by an authorised person. This release is not intended to be a financial promotion or offer to the public and the Company is not making an invitation to invest into the share capital of the Company.
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.
The Regulation Services Provider accepts no responsibility for the adequacy or accuracy of this release.